BACKGROUND: Glutathione S-transferase P1 (GSTP1), the abundant isoform of glutathione S-transferases (GSTs) in lung epithelium, plays an important role in cellular protection against oxidative stress and toxic foreign chemicals. It has been suggested that polymorphisms in the GSTP1 gene are associated with asthma and related phenotypes. As significant interindividual and interethnic differences exist in the distribution of xenobiotic-metabolizing enzymes, we have studied the GSTP1 Ile105Val polymorphism in patients with asthma in a Turkish sample. METHODS: GSTP1 Ile105Val polymorphism in exon 5 was determined in 210 patients with asthma (112 extrinsic and 108 intrinsic) and 265 control individuals without lung diseases and without history of allergy or atopy, using polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) techniques. RESULTS: The proportion of GSTP1 Val105 homozygotes was significantly lower in the patients with asthma than in the control individuals (3.8% vs 12.1%). The odds ratio for GSTP1 Val105 homozygotes vs all other genotypes was 0.29 (95%CL 0.13-0.64, p = 0.01) for asthmatics. The distribution of GSTP1 Ile105Val genotypes and the frequency of GSTP1 Val105Val homozygotes (3.7% vs 3.9%) was not significantly different between extrinsic and intrinsic asthmatics. CONCLUSION: These results suggest a significant association between GSTP1 Ile105Val polymorphism and susceptibility to asthma and that the GSTP1 Val105Val genotype may be protective against developing this disease.
BACKGROUND:Glutathione S-transferase P1 (GSTP1), the abundant isoform of glutathione S-transferases (GSTs) in lung epithelium, plays an important role in cellular protection against oxidative stress and toxic foreign chemicals. It has been suggested that polymorphisms in the GSTP1 gene are associated with asthma and related phenotypes. As significant interindividual and interethnic differences exist in the distribution of xenobiotic-metabolizing enzymes, we have studied the GSTP1Ile105Val polymorphism in patients with asthma in a Turkish sample. METHODS:GSTP1Ile105Val polymorphism in exon 5 was determined in 210 patients with asthma (112 extrinsic and 108 intrinsic) and 265 control individuals without lung diseases and without history of allergy or atopy, using polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) techniques. RESULTS: The proportion of GSTP1 Val105 homozygotes was significantly lower in the patients with asthma than in the control individuals (3.8% vs 12.1%). The odds ratio for GSTP1 Val105 homozygotes vs all other genotypes was 0.29 (95%CL 0.13-0.64, p = 0.01) for asthmatics. The distribution of GSTP1Ile105Val genotypes and the frequency of GSTP1Val105Val homozygotes (3.7% vs 3.9%) was not significantly different between extrinsic and intrinsic asthmatics. CONCLUSION: These results suggest a significant association between GSTP1Ile105Val polymorphism and susceptibility to asthma and that the GSTP1Val105Val genotype may be protective against developing this disease.
Authors: P S Gao; X Q Mao; M H Roberts; Y Arinobu; M Akaiwa; T Enomoto; Y Dake; M Kawai; S Sasaki; N Hamasaki; K Izuhara; T Shirakawa; J M Hopkin Journal: J Med Genet Date: 2000-05 Impact factor: 6.318
Authors: T Ishii; T Matsuse; S Teramoto; H Matsui; M Miyao; T Hosoi; H Takahashi; Y Fukuchi; Y Ouchi Journal: Thorax Date: 1999-08 Impact factor: 9.139
Authors: Michael J Holtzman; Jeffrey D Morton; Laurie P Shornick; Jeffrey W Tyner; Mary P O'Sullivan; Aurita Antao; Mindy Lo; Mario Castro; Michael J Walter Journal: Physiol Rev Date: 2002-01 Impact factor: 37.312
Authors: Timothy D Howard; Gerard H Koppelman; Jianfeng Xu; Siqun L Zheng; Dirkje S Postma; Deborah A Meyers; Eugene R Bleecker Journal: Am J Hum Genet Date: 2001-11-14 Impact factor: 11.025
Authors: Berran Yucesoy; Victor J Johnson; Zana L Lummus; Grace E Kissling; Kara Fluharty; Denyse Gautrin; Jean-Luc Malo; André Cartier; Louis-Philippe Boulet; Joaquin Sastre; Santiago Quirce; Dori R Germolec; Susan M Tarlo; Maria-Jesus Cruz; Xavier Munoz; Michael I Luster; David I Bernstein Journal: Toxicol Sci Date: 2012-05-17 Impact factor: 4.849
Authors: Daniel J Conklin; Petra Haberzettl; Russell A Prough; Aruni Bhatnagar Journal: Am J Physiol Heart Circ Physiol Date: 2009-03-06 Impact factor: 4.733
Authors: Yu-Fen Li; W James Gauderman; David V Conti; Pi-Chu Lin; Edward Avol; Frank D Gilliland Journal: Environ Health Perspect Date: 2008-03 Impact factor: 9.031
Authors: Cosetta Minelli; Raquel Granell; Roger Newson; Matthew J Rose-Zerilli; Maties Torrent; Sue M Ring; John W Holloway; Seif O Shaheen; John A Henderson Journal: Int J Epidemiol Date: 2009-12-23 Impact factor: 7.196